Yuichiro Yabe - Concepedia

Author

Yuichiro Yabe

Nagoya Medical Center

Also Known As

Hideki Takagi, Y Yabe, Y. YABE, Y. Yabe, YUICHIRO YABE, Yuichi Yabe, Yuichiro YABE, Yuichiro Yabe, Yuichiro. Yabe

123

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Nagoya Medical Center Toyohashi Municipal Hospital Ichinomiya Municipal City Hospital Nagoya University Kariya Toyota General Hospital

About

Yuichiro Yabe is an author at Nagoya Medical Center specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	669
2	Natural Sciences	10	10	243
3	Engineering	3	3	117
4	Allergy	2	2	46
5	Health Sciences	1	1	24

Yuichiro Yabe

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Synthesis of atrial natriuretic peptides and studies on structural factors in tissue specificity M. Sugiyama, Hiroshi Fukumi, Robert T. Grammer, Biochemical and Biophysical Research Communications Atrial Natriuretic PeptidesEngineeringTissue SpecificityMedicinePeptide Library	1984	84
Basic Fibroblast Growth Factor Has a Beneficial Effect on the Viability of Random Skin Flaps in Rats Naoki Ishiguro, Yuichiro Yabe, Takuya Shimizu, Annals of Plastic Surgery Tissue EngineeringSurgeryDermatologySkin RegenerationRandom Skin Flaps	1994	50
Highly potent and specific inhibitors of human renin. Takeshi Kokubu, Kunio Hiwada, E Murakami, Hypertension Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	1985	48
Irreversible inhibition of papain by epoxysuccinyl peptides. Carbon-13 NMR characterization of the site of alkylation Yuichiro Yabe, Dominique Guillaume, Daniel H. Rich Journal of the American Chemical Society Pharmaceutical ScienceBioorganic ChemistryBiochemistryIrreversible InhibitionNatural Sciences	1988	44
A highly potent and long-acting oral inhibitor of human renin. Kunio Hiwada, Takeshi Kokubu, E Murakami, Hypertension PharmacotherapyExperimental PharmacologyBlood PressureDrug ResistanceMolecular Pharmacology	1988	36
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis Toshihisa Kojima, Yuichiro Yabe, Atsushi Kaneko, Modern Rheumatology	2012	36
Study protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) Study Toshihisa Kojima, Atsushi Kaneko, Y. Hirano, Modern Rheumatology Rheumatoid DisorderRheumatologyAdverse EventsEpidemiologyDisease Management	2012	34
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis Toshihisa Kojima, Yuichiro Yabe, Atsushi Kaneko, Modern Rheumatology ImmunologyImmunotherapyPsoriatic ArthritisInflammatory ArthritisInflammation	2013	33
Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry Nobunori Takahashi, Shuji Asai, Tomonori Kobayakawa, Scientific Reports	2020	31
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies S. Hirabara, Nobunori Takahashi, Naoki Fukaya, Clinical Rheumatology ImmunologyBiological TherapyPharmacotherapyImmunotherapyAnti-tnf Monoclonal Antibodies	2014	29

Page 1